Abstract: Calcific aortic stenosis is now understood as a complex valvular degenerative process sharing many risk factors with atherosclerosis. Once patients develop symptomatic calcific aortic stenosis, the only effective treatment is aortic valve replacement. In the past decade, transcatheter aortic valve replacement (TAVR) has been developed as an alternative to surgery to treat severe calcific aortic stenosis. Cardiac imaging plays a pivotal role in the contemporary management of patients with calcific aortic stenosis, and particularly in patients being considered for TAVR, who demand detailed imaging of the aortic valve apparatus. In this review, we highlight the role of cardiac imaging for patient selection, procedural guidance, and evaluation of results of TAVR.
Introduction
Calcific aortic stenosis (AS), once thought to be a normal consequence of aging, is now understood as a complex valvular degenerative process sharing many risk factors with atherosclerosis. 1 Currently, there is no known treatment to prevent its development, no effective means to halt its progression, and no accepted pharmacologic regimen to decrease its severity; once patients develop severe symptomatic calcific AS, the only effective treatment is aortic valve replacement. 2, 3 Until recently, surgical aortic valve replacement was the only viable option for these patients. In the past decade, transcatheter aortic valve replacement (TAVR) has been developed as an alternative to surgery to treat severe calcific AS. 4, 5 This procedure is currently applicable in patients with severe trileaflet AS who are either not surgical candidates or have an exceedingly high surgical risk. With a prevalence of 3.4%, the burden of disease in the elderly due to severe AS is substantial. In North America, under current indications, approximately 100,000 elderly patients with severe AS are TAVR candidates, and about 10,000 patients become eligible for TAVR annually. 6 Already, this relatively new technique has been used in over 40 countries, accumulating to over 50,000 implantations. 7 TAVR has been shown to compare favorably with conventional surgical aortic valve replacement. 8 As experience is gained with this new technology, the applications for this procedure are likely to expand, eg, there is a recent report demonstrating the feasibility of TAVR in patients with bicuspid aortic valve. 9 The initial results of TAVR have been very encouraging and have generated a great deal of interest and enthusiasm among physicians taking care of patients with AS. 10 Furthermore, TAVR has resulted in marked improvements in health status and quality of life compared with standard therapy over 1 year of follow-up. 11 Paradoxical low-flow low-gradient AS, despite normal left ventricular (LV) ejection fraction, is a recently described entity that has been shown to be associated with a more advanced stage of the disease and worse prognosis. Dobutamine stress echo (DSE) greatly aids risk stratification and clinical decision-making in these patients. Valve calcium quantification by multidetector computed tomography (CT) and measurement of plasma brain natriuretic peptide may also be helpful for the management of patients with no LV flow reserve in whom DSE is often inconclusive. TAVR may eventually prove to be an attractive alternative to surgical AVR in both types of low-flow low-gradient severe AS, but this remains to be confirmed by future randomized studies. 12 Successful management of patients with severe AS and particularly patients being considered for TAVR demands detailed imaging of the aortic valve apparatus. Cardiac imaging plays a pivotal role in patient selection, procedure guidance, and evaluation of results. 13 In this review, we present advances in cardiovascular imaging as they relate to calcific AS and TAVR.
Aortic valve complex
The introduction of TAVR has renewed interest in the aortic valve complex. 14, 15 Recent review articles have emphasized the presence of a virtual annulus at the nadir of the leaflets, a coronet-shaped annulus following the insertion of the leaflets into the sinuses of Valsalva, and an annulus at the sinotubular junction 16 ( Figure 1 ). Successful TAVR deployment depends on precise measurements of these structures. Because of a limited number of prosthesis sizes (20, 23, 26 TAVR is currently performed only in patients with trileaflet AS, therefore analyzing the number of leaflets is crucial for patient selection. In patients with normal aortic leaflets, this is a relatively easy endeavor; however, in patients with heavily calcified leaflets and severe commissure fusion, this can be more difficult to ascertain. The three aortic cusps are named after the sinus of Valsalva, where they are situated, the right coronary cusp being situated in the sinus of Valsalva with the right coronary ostium, the left coronary cusp on the left coronary sinus of Valsalva, and the noncoronary cusp on the remaining sinus of Valsalva. In addition to housing the coronary ostia, the sinus of Valsalva provides space for the leaflets to expand and open fully. In the presence of a significant amount of calcification on the annulus or leaflets, the sinuses of Valsalva provide additional room for the calcium that is mobilized when a prosthesis is deployed. Determining the sinus of Valsalva diameter and volume will help predict when an excess amount of calcium may obliterate the sinus of Valsalva and potentially the coronary ostia. In addition, the maximal length of the right and left coronary cusps needs to be known in relation to the distance between the nadirs of the cusps to the coronary ostia. A long leaflet in a shallow sinus of Valsalva has the potential to obliterate the coronary ostia when a transcatheter prosthetic aortic valve is deployed.
Imaging techniques in aortic stenosis
The decision to intervene in a patient with AS is based on the presence of symptoms that can be attributed to the AS, the demonstration of severe AS, and the characterization of a suitable aortic valve complex for TAVR deployment. The hemodynamic evaluation of AS severity in the cardiac catheterization laboratory has been replaced by hemodynamic data derived from echo and Doppler methods. The American Heart Association/American College of Cardiology and the European Society of Cardiology guidelines define severe AS by echocardiography as a valve area of less than 1 cm 2 , an aortic valve area index of 0.6 cm 2 , a mean transvalvular gradient of 40 mmHg, and a peak transvalvular velocity of 4 m/second. 3, 17 Transthoracic echocardiography readily provides this information, as illustrated in Figure 2 .
In addition to transthoracic two-dimensional (2-D) echocardiography and spectral Doppler imaging, several imaging tools have emerged for the evaluation and management of patients with calcific AS being considered for or undergoing TAVR, and are the main topic of this review. -volumetric technique that provides multiplanar reorientation of key aortic valve structural components -Given the ovoid shape of the aortic valve annulus, volumetric three-dimensional CT provides accurate measurements of both the major and minor axes of the annulus, and the area -Best tool to determine size and plaque burden of abdominal aorta and iliac and femoral arteries -Best tool to determine aortic valve calcium burden -Becoming the standard for aortic annular measurements -CT plays a fundamental role in predicting the best C-arm orientation for the fluoroscopic angle to be used at time of prosthesis deployment Cardiac MRi -CMR is able to quantify the severity of AS, the presence of other types of outflow stenosis, such as HOCM, and subaortic membranes or CABG graft patency when selecting TAvR patients Fluoroscopy and advanced cineangiography -Fluoroscopy is the best tool to navigate catheters and devices during TAvR procedures -Advanced cineangiography facilitates radiographic images perpendicular to the valve plane in an optimal projection for TAvR deployment
Abbreviations: CT, computed tomography; MRi, magnetic resonance imaging; TAvR, transcatheter aortic valve replacement; CABG, coronary artery bypass surgery; AS, aortic stenosis; HOCM, hypertrophic obstructive cardiomyopathy; RT 3-D, real time three dimensional; CMR, cardiac magnetic resonance.
3-D echocardiography in aortic stenosis
The standard echocardiographic assessment of AS consists of 2-D morphologic evaluation of the aortic valve and Dopplerderived mean and peak gradients, as well as the continuityequation effective aortic valve area. 18 2-D echocardiography usually distinguishes a bileaflet from a trileaflet aortic valve, and permits fair characterization of calcium burden and leaflet motion restriction; however, the spatial resolution of 2-D echo transesophageal echocardiography (TEE) is usually inadequate to measure the aortic valve orifice area accurately. Even with 2-D TEE, which provides better spatial resolution, it is difficult to select the precise plane that transects the smallest aortic valve orifice.
Real-time (RT) 3-D TEE allows for an en-face "surgeon's view" of the aortic valve, providing detailed morphologic description of the aortic valve 19 ( Figure 3 ). RT 3-D TEE is emerging as the preferred echocardiographic tool for the morphologic and functional characterization of the stenotic aortic valve [20] [21] [22] [23] [24] [25] ( Figure 4 ). RT 3-D TEE facilitates the obtaining of the cross-sectional plane where the aortic valve area is smallest, usually at the tips of the leaflets. 24 The 3-D-based biplane (xPlane mode) or multiplane (3-D zoom or fullvolume modes) can be used for this purpose ( Figure 5 ).
In addition to improving the planimetric measure of the aortic valve orifice, RT 3-D TEE can improve the estimation of the aortic valve area from the continuity equation, by providing a better measure of the true LV outflow tract (LVOT) area. It is now well recognized that the LVOT frequently has an oval shape and is not a perfect circle. RT 3-D TEE allows for a better characterization of the oval-shaped LVOT, 26 thereby improving the accuracy of the continuity equationderived aortic valve area.
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3-D echocardiography in patients undergoing TAvR procedures
TAVR demands a multimodality-imaging team-based approach (involving echocardiography, angiography and fluoroscopy, CT angiography [CTA], and cardiac magnetic resonance imaging [CMRI]) throughout preprocedural planning, intraprocedural guidance, immediate evaluation of results, and long-term follow-up. 13 Patients undergoing TAVR require the expert use of various imaging modalities, each of which has its own strengths and limitations. In this section, we highlight the pivotal role echo/Doppler imaging and RT 3-D TEE play in the continuum of care of patients undergoing TAVR. junction dimension, and left main trunk ostia height 30, 31 ( Table 2 and Figure 6 ). In addition, RT 3-D TEE helps immensely in characterizing the LVOT size and shape and demonstrating the absence of subvalvular obstruction. 26 All of these parameters are used to determine the feasibility of a TAVR procedure and the appropriate prosthetic size. 32, 33 Important findings regarding calcium deposits on or around the aortic valve include extent and asymmetry of leaflet involvement, mobile calcium deposits potentially more likely to embolize, and extension of calcium deposits in the LVOT and sinotubular junction. RT 3-D TEE facilitates this characterization.
Preprocedural planning
intraprocedural guidance TAVR is heavily dependent on fluoroscopic and angiographic methods. 34 RT 3-D TEE supplements these X-ray-based procedures by providing a 3-D rendition of the aortic valve complex, facilitating maneuvering of the delivery system and proper positioning of the aortic prosthesis 32 ( Table 2 and Figure 7 ). RT 3-D TEE also plays a central role in the prompt recognition of intraprocedural TAVR complications and facilitates the appropriate management of these potential problems.
Postprocedure assessment
Echocardiographic methods are uniquely suited for the immediate and long-term postprocedure assessment of TAVR procedures. Echocardiography and Doppler methods permit a detailed functional and structural assessment of the newly deployed transcatheter aortic bioprosthesis (Table 2 and Figure 7) . Immediately after the prosthesis has been deployed, 2-D and 3-D TEE permit confirmation of appropriate prosthesis position and stability, evaluation of normal leaflet motion, and characterization of the presence, severity, and location of prosthetic and periprosthetic aortic regurgitation (Figure 8 ). Long-term post-TAVR assessment also relies mainly on echocardiographic methods. LV size and function and presence and severity of mitral regurgitation are assessed; prosthesis stability, leaflet motion, prosthetic gradients, and presence and degree of prosthetic and periprosthetic aortic regurgitation are evaluated by echocardiography.
Computed tomographic angiography
A multimodality imaging approach to aortic valve stenosis incorporates CTA as a volumetric technique that provides multiplanar reorientation of key aortic valve structural components. 35 Such features of CTA allow careful examination of valve characteristics (bicuspid valves or stenotic trileaflet valves), sinuses, and aorta under scrutiny for either surgical or percutaneous valve replacement. This is in addition to assessment of iliofemoral access for percutaneous procedures and the position of the cardiac apex for a transapical approach. 36, 37 Initial evaluation of potential candidates usually employs 2-D TEE to assess the severity of stenosis and actual valve characteristics. 38, 39 However, the degree of calcific degeneration of the stenotic valve limits the exact determination of a bicuspid versus trileaflet valve in many cases. Definition of structural tissue compared to calcium is a strength of CTbased technologies. The extent and severity of aortic valve leaflet calcification can be quantified by either contrast or noncontrast images, although leaflet morphology requires contrasted studies. Once oriented in orthogonal planes to view the commissures, it is easy to define two or three cusps. Functional bicuspid valves are seen frequently and maintain a triangular shape to the valve opening, but the fused raphe results in a nonuniform triangle. Since the definition of a bicuspid valve is considered a limitation of percutaneous treatment of aortic valve stenosis, then correct identification is important. An unequal but still triangular orifice seen with functional bicuspid valve may still allow a percutaneous TVAR approach. In conjunction with the orifice shape is the actual surface area at the end of systole, defining the severity of stenosis. Generally, the orifice and leaflet tips are visualized well, despite higher heart rates in patients with severe AS; however, heart rates over 100 bpm may be problematic for CTA. Planimetry of the orifice is well correlated between anatomic assessments of AS by CT compared to functional assessments by echocardiography. 38 Critical issues that must be evaluated before a decision for TAVR or surgical AVR relate to preoperative risk assessment, including such findings as a "porcelain aorta" or large annular size. Commercial-release TAVR is limited to nonoperative or very high-surgical-risk individuals, in which the valve device sizes are limited to 23, 26, or 29 mm. 4, 5 Therefore, CTA provides a technique to allow detailed interrogation of the aortic valve annulus and the relationship to the coronary arteries, which helps to either include or exclude an individual for a TAVR procedure.
Given the ovoid shape of the aortic valve annulus, volumetric 3-D CT provides accurate measurements of both the major and minor axes of the annulus and the area (Figure 9 ). These measurements are critical for choosing an appropriately sized device. An oversized prosthesis can result in annular and/or sinotubular junction rupture or coronary artery occlusion, 41, 42 whereas under sizing the valve device may result in significant perivalvular leaks and aortic insufficiency, or more catastrophically device migration and embolization. 36, 40, 42 Definition of the correct annular orientation and axis is complex. Shown in Figure 9 are the similarities and differences between 3-D TEE and CTA using a similar multiplanar reformation technique. 15, 30 The CTA images are less affected by calcium than are the echocardiographic images, leading to better determination of the annular size. Early device trials solely used echocardiography to determine annular size, but more recently CTA has become the more accepted standard for annular measurements when technically adequate. 30, 40 Positioning of the two axes requires careful adjustment of the angulation of this 3-D structure at the systole, due to the annular insertion, as described previously.
Once the angles are set, panning through the aortic valve short-axis image set is performed until the plane just below the insertion of the three-cusp position is noted. At this point, the area is determined, from which the major and minor axes are measured. Some investigators have used the mean annular measurement for deciding appropriate device size, while others use the area of the annulus. A rough guide is that the upper-limit area of 420 mm 2 is used for 23 mm valves, and 530 mm 2 is used for the 26 mm valve. 30, 40, 41 Lastly, the clear identification of the coronary ostia allows determination of the distance between the annulus and the ostium as it relates to the length of each leaflet. Concern about coronary ostium occlusion is generated when either the leaflet length is longer than the height (annulus to ostium) or the height is less than 10 mm. Orthogonal image reorientation using CTA provides accurate measurement of these key parameters. 43 Routinely, CT can assess the thoracic aorta for aneurysmal dilatation, stenosis to the major vessel, and large ascending or arch atheromatous plaques at risk of embolization during the procedure 35 ( Figure 10) . The relationship between the aortic root and LV cavity is also carefully scrutinized for potential excessive angulation or mitral valve chordal entrapment when a transapical approach is entertained. 
Figure 10
Shown are volumetric three-dimensional reconstructions of the entire vascular tree in a patient screened for TAvR. Note in the small focal images the greater than 50% circumferential calcium (left) compared to the normal vessel (right). This finding could limit peripheral arterial access for a TAVR procedure, since vascular stretch is impaired. Abbreviations: TAvR, transcatheter aortic valve replacement.
Distal to the thoracic aorta, the abdominal aorta and iliac vessels extending to the common femoral artery are assessed for size and plaque burden (Figure 10) . The large-diameter delivery sheaths required for device deployment (between 18 and 28 French, minimum of 7-9 mm for 23 and 26 mm valves, respectively) necessitate accurate femoral-to-iliac artery and distal aortic measurements. These vessels must "stretch" around these large sheaths for delivery of the valve through the aorta, across the arch, and ultimately across the native valve. CT provides information about the circumferential nature of calcification, plaque stenosis, and minimal luminal diameter. 35, 36 Circumferential calcification does not stretch, thereby increasing the risk of arterial dissection or perforation. The entire course of the vascular tree can be assessed using volumetric 3-D-rendered displays of vessel angulation and tortuosity. Different methods have been proposed to help define the characteristics favorable for peripheral vascular access, 44 but we find that direct orthogonal cross-sectional size measurement is the most useful.
In addition, CT plays a fundamental role in predicting the best C-arm orientation for the fluoroscopic angle to be used at the time of prosthesis deployment ( Figure 11 ). This requires careful alignment of the aortic annulus defined by the nadir of each coronary cusp. Clear separation of each cusp allows appropriate alignment of the valve under balloon deployment. Planning appears to reduce total contrast requirements, and with less cinematic angiography the radiation dose is also reduced.
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Cardiac magnetic resonance imaging CMRI in pure AS is limited, though it still provides useful information in the preprocedural evaluation of TAVR patients by excluding other types of cardiomyopathies, predominant aortic insufficiency, or lesser degree of stenosis. The calcific degenerative process of valvular AS limits CMRI due to signal absorption or susceptibility artifacts causing blackout regions around calcium. Several studies note similar sensitivity for detection of valve stenosis, with close correlation between CMRI, cardiac CT, and TEE measurements of planimetric valve area. CMRI is still able to quantify the severity of AS, the presence of other types of outflow stenosis such as HOCM (hypertrophic obstructive cardiomyopathy) and subaortic membranes or CABG (coronary artery bypass graft) graft patency when selecting TAVR patients. Accurate severity assessment of AS and the valve characteristics (bi-or tricuspid) are also within the scope of a CMRI examination. The location of outflow obstruction and the measurement of peak aortic valve velocity are performed using a phase-contrast imaging sequence, as shown in Figure 12 . 37, 45 Cine (steady-state free precession) CMRI can be used to identify the presence of congenital valvular abnormalities, such as bicuspid aortic valves. Also, CMRI quantitates the severity of aortic valve area reduction by planimetry, similar to CTA. 46 This correlates with TEE. 47 Also, AS is often concurrent with valvular regurgitation, and quantitation by CMRI provides an estimate of the volumetric severity of insufficiency by using the phase-contrast technique. 48 
Advanced angiography
During TAVR, valve positioning and implantation is primarily guided by fluoroscopy. In order to position the valve optimally, it is important to obtain fluoroscopic images that are perpendicular to the valve plane in what is referred to as a "coplanar" view or optimal projection (OP). Ideally, this is a projection that is perpendicular to the valve plane, with all three sinuses of Valsalva clearly visualized. This is often performed through acquisition of multiple aortic root angiograms in various projections to determine the best view, with a significant contrast burden. Recent work has demonstrated that an OP can be determined using volumetric data sets derived from preprocedural multislice CT (MSCT) with good accuracy. 36, 49 In patients with significant renal impairment, the 80-120 mL of contrast needed for MSCT precludes use of this preprocedurally in those with adequate TEE imaging. As such, alternative strategies for in-room determination of the OP utilize aortic root angiography. These approaches address the impact of differences of patient positioning on the CT scanner compared to the hybrid lab table, especially in the case of patient positioning necessary for transapical TAVR (patient rotated rightward and caudal).
One approach utilizes two aortic root angiograms obtained in orthogonal projections (C-THV; Paieon, New York, NY, USA) using a software solution that identifies a series of 
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imaging techniques in TAvR suitable angles for selection of an OP by the operator. This technology has been evaluated and confirmed to be accurate for OP determination compared to preprocedural MSCT for TAVR, and can be used for positioning as well as at the time of valve implantation. 50 Another approach is through the acquisition of 3-D volumetric data using in-room C-arm CT with rotational angiography (RA). This has been well investigated for guidance of peripheral and cerebral interventions. Aortic root angiography is performed using commercial hardware and software during breath hold with rapid ventricular pacing with low-contrast injection rates of 4-8 mL/second for a total of 4-6 seconds during rotational angiography. These acquisitions are rapidly converted to 3-D reconstructions that are used to determine the OP for valve implantation. This approach has recently been validated, and it appears that 3-D RA compares favorably to multidetector CT (MDCT) in the determination of OP and final valve-visualization angle. 51, 52 In one recent study, the OP was found to be a mean of 4.9° LAO (left anterior oblique) and 8.8° caudal projection for valve implantation. 52 There was very high correlation of the two approaches, and the mean difference in OP between 3-D RA and MDCT was found to be 4.6° ± 3.5°. Of note, the OP was found to be 3° more caudal using 3-D RA compared to MSCT, likely related to patient-position differences. Research into the clinical impact of using in-room aortography for procedural planning and outcomes (procedural time, appropriate valve positioning, and perivalvular leak) in TAVR is under investigation at this time.
Conclusion
Cardiac imaging plays a pivotal role in the contemporary management of patients with calcific AS. Recent advances in 3-D echocardiography allow for precise functional/ morphologic characterization of the aortic valve complex, a better estimate of aortic valve area, and RT pre-, intra-, and post-TAVR intervention imaging guidance. CT is playing an increasing role in the patient selection and prosthesis-size determination in patients undergoing TAVR procedures. This volumetric technique provides multiplanar reorientation of key aortic valve structural components, providing accurate measurements of both the major and minor axes of the annulus and the area. CMRI is able to quantify the severity of AS, the presence of other types of outflow stenosis, such as HOCM, and subaortic membranes or CABG graft patency when selecting TAVR patients. Advanced angiographic methods, including aortic root angiograms obtained in orthogonal projections and acquisition of 3-D volumetric data using in-room C-arm CT with rotational angiography, have been developed to optimize appropriate valve positioning during TAVR procedures, and presently are undergoing clinical evaluation.
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